Slashdot Mirror


User: __aayllo8548

__aayllo8548's activity in the archive.

Stories
0
Comments
2
First seen
Last seen
Profile
(view on slashdot.org)

Comments · 2

  1. LyX, DocBook, TeXmacs on Modern LaTeX Replacement? · · Score: 1

    While LyX is generally used with a LaTeX backend, it also has "SGML-tools support (both LinuxDoc and DocBook DTDs)".

    There's also a relatively new project, TeXmacs (www.texmacs.org).
    From the FAQ:
    What is TeXmacs?
    Answer. GNU TeXmacs * is a free scientific text editor, which was both inspired by TeX and GNU Emacs. * allows you to write structured documents via a wysiwyg (what-you-see-is-what-you-get) and user friendly interface. * lets you create new styles. * implements high-quality typesetting algorithms and TeX fonts, which helps you to produce professionally looking documents. * is suitable as an interface for computer algebra systems, as the high typesetting quality goes through for automatically generated formulas. * can be highly customized as it supports the Guile/Scheme extension language. * lets you export your documents to PS and PDF and offers both import and export to HTML, LaTeX, Scheme, Verbatim and Xml. We would very much appreciate your help for writing and improving converters for TeXmacs documents.
    Although TeX fonts are mentioned in the FAQ above, the current version also supports the use of Type 1 and TrueType fonts.

  2. Re:My Grandma on Japanese Scientists Make Alzheimers Progress · · Score: 1

    Regarding diagnosis: as far as I can tell from a brief look at the literature (not my area of expertise), it seems that there are lots of people trying to develop imaging (MRI and PET) and biochemical (looking at levels of proteins in the cerebrospinal fluid) tests for alzheimers. It doesn't look like any have been widely adopted yet, though. Search for "alzheimers" and "diagnosis" in google scholar if you are interested.

    Regarding therapy, as someone else has noted, there's always the possibility of making things worse. You might say, so what, I'm only losing time that isn't valuable to me. But the patients point of view about that might change after it's too late. And you could argue that accelerating the disease or causing some other problem would prevent the patient from benefiting from other treatments that are in development.